Clinical Trial Update: Safety Study of IL-7 in HIV-infected Patients (Inspire) [Phase 1]

View source ↗

Summary

Phase 1 safety study of interleukin-7 (IL-7) in HIV-infected patients with lymphopenia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Lymphopenia

Drugs mentioned

• Interleukin-7 (interleukin-7)

Snippet

Sponsor: Cytheris SA | Conditions: HIV Infections, Lymphopenia | Phase 1 | Status: COMPLETED